Drug Delivery Device Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

Drug Delivery Device Market Overview

The global Drug Delivery Device Market is poised for significant growth, with projections indicating a compound annual growth rate (CAGR) of 6.8% from 2025 to 2030. The market, valued at approximately $150 billion in 2025, is expected to reach $210 billion by 2030. This growth is driven by advancements in drug delivery technologies, increasing prevalence of chronic diseases, and rising demand for self-administration devices.

Market Size and Share Analysis

The market is segmented by product type, process, application, end-use, and region. By product type, the market is dominated by injectable drug delivery devices, which accounted for 45% of the market share in 2025. Other segments include transdermal patches, implantable devices, and inhalation devices.

By Product Type

• Injectable Devices: 45% market share
• Transdermal Patches: 20% market share
• Implantable Devices: 15% market share
• Inhalation Devices: 10% market share
• Others: 10% market share

By Application

• Cardiovascular Diseases: 25% market share
• Oncology: 20% market share
• Urology: 15% market share
• Diabetes: 20% market share
• Infectious Diseases: 10% market share
• Others: 10% market share

By End-Use

• Hospitals: 40% market share
• Homecare Settings: 30% market share
• Clinics: 20% market share
• Others: 10% market share

Key Players and Competitive Landscape

The market is highly competitive, with key players such as Kindeva, Zosano Pharma, Lohmann Therapie-Systeme, SHL, Ypsomed, West Pharma, Becton Dickinson, Stevanato Group, Boston Scientific, Bayer, Baxter, Mylan, Janssen, Capsugel, Theraject, SurModics, and Generex Biotechnology dominating the landscape. These companies are focusing on strategic partnerships, mergers, and acquisitions to strengthen their market position.

Market Trends and Drivers

The increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer is a major driver for the market. Additionally, the shift towards self-administration of drugs and the development of advanced drug delivery systems are contributing to market growth. The rise in geriatric population and the growing demand for minimally invasive drug delivery methods are also significant factors.

Regional Analysis

North America held the largest market share in 2025, accounting for 40% of the global market, followed by Europe with 30%. The Asia-Pacific region is expected to witness the highest growth rate of 8.5% during the forecast period, driven by increasing healthcare expenditure and rising awareness about advanced drug delivery systems.

By Region

• North America: 40% market share
• Europe: 30% market share
• Asia-Pacific: 20% market share
• Latin America: 5% market share
• Middle East & Africa: 5% market share

Market News on Policy and Companies

Recent policy changes, such as the FDA's approval of new drug delivery devices and the European Medicines Agency's (EMA) guidelines on advanced therapy medicinal products (ATMPs), are expected to positively impact the market. Companies like Becton Dickinson and West Pharma have recently launched innovative drug delivery devices, further driving market growth.

Segment Forecasts 2025 - 2030

The injectable drug delivery devices segment is expected to maintain its dominance, with a projected CAGR of 7.2%. The transdermal patches segment is also anticipated to grow significantly, driven by advancements in patch technology and increasing demand for non-invasive drug delivery methods. The oncology application segment is expected to witness the highest growth rate of 9%, owing to the rising prevalence of cancer and the development of targeted drug delivery systems.

Segment Forecasts

• Injectable Devices: CAGR of 7.2%
• Transdermal Patches: CAGR of 6.5%
• Implantable Devices: CAGR of 6.0%
• Inhalation Devices: CAGR of 5.8%
• Oncology Applications: CAGR of 9.0%

Conclusion

The global Drug Delivery Device Market is set to experience robust growth over the next five years, driven by technological advancements, increasing prevalence of chronic diseases, and favorable regulatory policies. Key players are expected to continue investing in R&D and strategic partnerships to capitalize on emerging opportunities. The market's future looks promising, with significant growth anticipated across all segments and regions.